Ming Z - Search Results

1

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

Ming Z, Lim SY, Stewart A, Pedersen B, Shklovskaya E, Menzies AM, Carlino MS, Kefford RF, Lee JH, Scolyer RA, Long GV, Rizos H. Ming Z, et al. J Invest Dermatol. 2023 Jul;143(7):1246-1256.e8. doi: 10.1016/j.jid.2023.01.017. Epub 2023 Feb 1. J Invest Dermatol. 2023. PMID: 36736995

2

Mitogen-activated protein kinase dependency in BRAF/RAS wild-type melanoma: A rationale for combination inhibitors.

Ming Z, Lim SY, Kefford RF, Rizos H. Ming Z, et al. Pigment Cell Melanoma Res. 2020 Mar;33(2):345-357. doi: 10.1111/pcmr.12824. Epub 2019 Sep 25. Pigment Cell Melanoma Res. 2020. PMID: 31518489

3

Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.

Ming Z, Lim SY, Rizos H. Ming Z, et al. Biomolecules. 2020 Oct 15;10(10):1447. doi: 10.3390/biom10101447. Biomolecules. 2020. PMID: 33076392 Free PMC article. Review.

4

Melanoma Cell State-Specific Responses to TNFα.

Lim SY, Alavi S, Ming Z, Shklovskaya E, Fung C, Stewart A, Rizos H. Lim SY, et al. Among authors: ming z. Biomedicines. 2021 May 26;9(6):605. doi: 10.3390/biomedicines9060605. Biomedicines. 2021. PMID: 34073253 Free PMC article.

5

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling.

Park JJ, Stewart A, Irvine M, Pedersen B, Ming Z, Carlino MS, Diefenbach RJ, Rizos H. Park JJ, et al. Among authors: ming z. Cancer Gene Ther. 2022 Oct;29(10):1384-1393. doi: 10.1038/s41417-022-00457-2. Epub 2022 Mar 29. Cancer Gene Ther. 2022. PMID: 35352024 Free PMC article.

6

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.

Shklovskaya E, Pedersen B, Stewart A, Simpson JOG, Ming Z, Irvine M, Scolyer RA, Long GV, Rizos H. Shklovskaya E, et al. Among authors: ming z. Cancers (Basel). 2022 Oct 3;14(19):4830. doi: 10.3390/cancers14194830. Cancers (Basel). 2022. PMID: 36230753 Free PMC article.

7

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.

Lim SY, Shklovskaya E, Lee JH, Pedersen B, Stewart A, Ming Z, Irvine M, Shivalingam B, Saw RPM, Menzies AM, Carlino MS, Scolyer RA, Long GV, Rizos H. Lim SY, et al. Among authors: ming z. Nat Commun. 2023 Mar 18;14(1):1516. doi: 10.1038/s41467-023-36979-y. Nat Commun. 2023. PMID: 36934113 Free PMC article.

8

Ex vivo tissue modelling informs drug selection for rare cancers.

Lee JH, Ming Z, Cheung VKY, Pedersen B, Wykes JJ, Palme CE, Clark JJ, Gupta R, Rizos H. Lee JH, et al. Among authors: ming z. Int J Cancer. 2024 Apr 1;154(7):1158-1163. doi: 10.1002/ijc.34802. Epub 2023 Dec 7. Int J Cancer. 2024. PMID: 38059815

9

Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed.

Yang S, Liang H, Li X, Qian J, Ming Z. Yang S, et al. Among authors: ming z. Hepatol Int. 2024 May 8. doi: 10.1007/s12072-024-10676-4. Online ahead of print. Hepatol Int. 2024. PMID: 38717694 No abstract available.

10

ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.

Luo W, Zou Z, Nie Y, Luo J, Ming Z, Hu X, Luo T, Ouyang M, Liu M, Tang H, Xie Y, Peng K, Chen L, Zhou J, Luo Z. Luo W, et al. Among authors: ming z. Cell Death Dis. 2024 May 6;15(5):319. doi: 10.1038/s41419-024-06672-z. Cell Death Dis. 2024. PMID: 38710705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

536 results

Search Page